Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use

33个州和哥伦比亚特区合法化医用大麻的地图不断扩大，反映了 增加成人大麻使用的正常化。成年人的合法使用开始改变人们对风险的看法 年轻人和成年人都是如此，人们对大麻危害的认识正在减少。青春期态度 对大麻的态度正在变得更加积极，大麻使用率在许多州都在上升 大麻已经合法化。在这种背景下，治疗青少年吸食大麻很可能成为 难度越来越大，对更有效的干预策略的需求也更加迫切。所处的上下文 父母是医用大麻(MM)的合法使用者，这可能会给他们的后代带来额外的风险。这个 拟议的第1A/1B阶段治疗开发研究将涉及一种混合方法方法来制定 大麻行动和做法(CAP)干预。CAP是一种以家长为中心的干预措施，以帮助家长MM 用户解决了青少年大麻的使用问题。研究将分两个阶段进行。在第一阶段，将有3个重点小组 进行以告知干预交付的结构、内容和背景，以从以下方面获得反馈 目前合法使用MM的父母，从青少年那里获得反馈，以及药房工作人员 获取有关药房支持传播的可行性的信息。在第二阶段，试点评估 将进行CAP，随机将60名MM父母分配到CAP(n=30)或延迟的CAP等待名单 (WL)状态(n=30)。父母和他们的青少年将在基线、3个月和6个月后接受评估 基线。主要结果将是青少年使用大麻和对大麻危害性的看法。 次要结果将包括养育子女的行为，如青少年接触大麻、交流 劝阻青少年使用大麻，并设定期望。我们假设CAP将与 与WL条件相比，治疗前后的结果明显更积极。我们还将检查关键 变化的目标，包括父母对大麻危害性的看法的变化，父母监测，父母 胜任感和父母行为意图。多方法、多源数据采集将 包括父母和青年报告和生物尿液分析。这项研究旨在评估 CAP，一种新的以理论为指导、以经验为基础、短暂的早期干预，用于帮助父母法律医疗 大麻使用者支持吸食大麻的青少年戒除大麻。

The expanding map of 33 states and the District of Columbia with legalized medical marijuana reflects an increased normalization of adult cannabis use. Legal use by adults is beginning to shift perceptions of risk among youth and adults alike, with perceptions of the harmfulness of marijuana use decreasing. Adolescent attitudes toward marijuana are becoming more positive and rates of marijuana use are rising in many states where cannabis has been legalized. Within this context, treating adolescent marijuana use is likely to become increasingly difficult and the need for more effective intervention strategies more urgent. The context in which parents are legal users of medical marijuana (MM) may pose an additional set of risks for their offspring. The proposed Stage 1A/1B treatment development research will involve a mixed-methods approach to formulating the Cannabis Actions and Practices (CAP) intervention. CAP is a parent-focused intervention to help parent MM users address adolescent marijuana use. The study will occur in two phases. In Phase I, 3 focus groups will be conducted to inform the structure, content, and context for the interventions’ delivery, to obtain feedback from parents who are currently legal users of MM, to obtain feedback from adolescents, and for dispensary personnel to obtain information about the feasibility of dispensary-supported dissemination. In Phase II, a pilot evaluation of CAP will be conducted, with 60 MM parents randomly assigned to CAP (n=30) or to a delayed CAP wait-list (WL) condition (n=30). Parents and their adolescents will be assessed at baseline and 3, and 6 months after baseline. Primary outcomes will be adolescent marijuana use and perceptions of marijuana harmfulness. Secondary outcomes will include parenting behaviors such as youth exposure to marijuana, communications discouraging adolescent marijuana use, and setting expectations. We hypothesize that CAP will be associated with significantly more positive pre-to-post outcomes, compared to the WL condition. We will also examine key targets of change, including changes in parent perceptions of marijuana harmfulness, parent monitoring, parent sense of competence, and parent behavioral intentions. The multi-method, multi-source data collection will include parent and youth report and biological urine assays. The study is designed to evaluate the promise of CAP, a novel theory-guided, empirically based, brief early intervention, for helping parent legal medical marijuana users support marijuana abstinence in their marijuana-involved adolescents.